e-learning resources

ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Asthma and allergy: from the bench to the bedside

Poster Discussion
Chairs: I. Vachier (Montpellier, France), S. Dahlén (Stockholm, Sweden)

Download all media

Download all media

LSC - 2017 - IL-1R1 but not IL-18Rbeta or IL-18BP contribute to the beneficial effects of IL-37 on experimental asthma M. Wegmann (Borstel, Germany)
LSC - 2017 - Evaluation the effect of bronchoconstriction on airway epithelial cells responses in asthma M. Quesada Del Bosque (Southampton, United Kingdom)
Allergen immunotherapy modulates pro- and antioxidant status patients with bronchial asthma L. Lazarenko (ST PETERSBURG, Russian Federation)
Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry B. Hutyrova (Olomouc, Czech Republic)
Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. J. Stril (Dorval, QC, Canada)
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis J. Cho (Seoul, Republic of Korea)
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD J. Kwon (Chuncheon-Si, Gangwon-Do, Republic of Korea)
AUSTRI and VESTRI LABA Safety studies subgroup analysis of asthma exacerbations and SAEs comparing FSC and FP by ICS dose I. Raphiou (RTP, United States of America)
Dampness at home and asthma in schoolchildren V. Micevska (Skopje, FYROM (Macedonia))
Occurrence of depression in asthmatics and its impact on asthma control and quality of life. S. Batra (DELHI (NEW DELHI), India)
Factors influencing on influenza vaccination among south korean adult asthma : a nationwide population-based cross-section study C. Han (Koyang, Republic of Korea)
Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial P. Hellings (Leuven, Belgium)
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis S. Weinstein (Hunitngton Beach, United States of America)
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis A. Khan (Chilly Mazarin Cedex, France)
IL-4/13-induced up-regulation of METEORIN-LIKE (ML) in alveolar macrophages promotes epithelial CCR3 expression X. Yao (Nanjing, Jiangsu, China)
Characterization of CD4-endotypes in severe allergic asthma for future precision medicine G. Ulrich-Merzenich (Bonn, Germany)
Endotoxin exposure increases LL-37, but not calprotectin, in healthy human airways M. Smith (Gothenburg, Sweden)
Risks for asthma exacerbations in patients with type 2-low endotype Y. Ishiyama (Kyoto, Japan)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.